We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-13.3%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$580M
AUM Growth
-$257M
Cap. Flow
-$134M
Cap. Flow %
-23.05%
Top 10 Hldgs %
37.84%
Holding
94
New
2
Increased
24
Reduced
33
Closed
31

Top Buys

Rank Stock Value
1
WMGI
Wright Medical Group Inc
WMGI
+$13.2M
2
INSP icon
Inspire Medical Systems
INSP
+$9.36M
3
IRTC icon
iRhythm Holdings
IRTC
+$7.84M
4
IMMU
Immunomedics Inc
IMMU
+$7.22M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$7.21M

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$36.8M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$17.3M
3
APLS
Apellis Pharmaceuticals
APLS
+$13.6M
4
AGN
Allergan plc
AGN
+$12M
5
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 83.54%
2 Industrials 3.13%
3 Technology 2.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV
76
DELISTED
KalVista Pharmaceuticals
KALV
– –
-17,551
Closed -$389K
KURA icon
77
Kura Oncology
KURA
$793M
– –
-11,800
Closed -$232K
LITS
78
Lite Strategy Inc
LITS
$32.4M
– –
-2,227
Closed -$111K
PODD icon
79
Insulet
PODD
$11.8B
– –
-36,160
Closed -$4.32M
PTGX icon
80
Protagonist Therapeutics
PTGX
$8.55B
– –
-11,400
Closed -$138K
SYRE icon
81
Spyre Therapeutics
SYRE
$8.5B
– –
-518
Closed -$89K
TLPH icon
82
Talphera
TLPH
$68M
– –
-3,689
Closed -$187K
ZLAB icon
83
Zai Lab
ZLAB
$2.07B
– –
-12,589
Closed -$439K
ONC
84
BeOne Medicines Ltd
ONC
$33.9B
– –
-11,227
Closed -$1.39M
RVNC
85
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-11,234
Closed -$146K
MRNS
86
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-4,200
Closed -$70K
ABMD
87
DELISTED
Abiomed Inc
ABMD
– –
-1,626
Closed -$424K
CCXI
88
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-17,811
Closed -$166K
SRRA
89
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-1,027
Closed -$23K
ATRS
90
DELISTED
Antares Pharma, Inc.
ATRS
– –
-47,280
Closed -$156K
NBRV
91
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
– –
-153
Closed -$93K
MYOK
92
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-4,051
Closed -$203K
TTPH
93
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-1,991
Closed -$19K
ARRY
94
DELISTED
Array Biopharma Inc
ARRY
– –
-794,868
Closed -$36.8M
1 2 3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Sectoral Asset Management held 94 positions worth $580M, down 31% from $836M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sectoral Asset Management withdrew a net $134M in Q3 2019, closing 31 positions and reducing 33 holdings. Its most notable exit was Array Biopharma Inc, an estimated $36.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Industrials and Technology.

Against the trend, Sectoral Asset Management opened a new position in Tabula Rasa HealthCare, Inc. Common Stock worth $6.63M.

  • Sectoral Asset Management's largest Q3 2019 buy was Tabula Rasa HealthCare, Inc. Common Stock: 120,600 shares worth $6.63M.
  • Sectoral Asset Management added most to Wright Medical Group Inc in Q3 2019, an estimated $13.2M increase.
  • Sectoral Asset Management's biggest Q3 2019 reduction was Alnylam Pharmaceuticals, cutting an estimated $17.3M.
  • Sectoral Asset Management fully exited Array Biopharma Inc in Q3 2019, selling an estimated $36.8M.
  • Sectoral Asset Management's ten largest holdings make up 38% of its $580M portfolio in Q3 2019.
  • Sectoral Asset Management opened 2 new positions and closed 31 in Q3 2019.
  • Sectoral Asset Management's portfolio value fell 31% quarter-over-quarter to $580M.

Based on Sectoral Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.